184 related articles for article (PubMed ID: 27028352)
1. Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine.
Filali I; Belkacem MA; Ben Nejma A; Souchard JP; Ben Jannet H; Bouajila J
J Enzyme Inhib Med Chem; 2016; 31(sup1):23-33. PubMed ID: 27028352
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of new isoxazoline derivatives from harmine and evaluation of their anti-Alzheimer, anti-cancer and anti-inflammatory activities.
Filali I; Bouajila J; Znati M; Bousejra-El Garah F; Ben Jannet H
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):371-6. PubMed ID: 25068731
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of New Harmine Isoxazoles and Evaluation of their Potential Anti-Alzheimer, Anti-inflammatory, and Anticancer Activities.
Filali I; Romdhane A; Znati M; Jannet HB; Bouajila J
Med Chem; 2016; 12(2):184-90. PubMed ID: 26362768
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel 1,2,3-triazole linked coumarinopyrazole conjugates as potent anticholinesterase, anti-5-lipoxygenase, anti-tyrosinase and anti-cancer agents.
Chekir S; Debbabi M; Regazzetti A; Dargère D; Laprévote O; Ben Jannet H; Gharbi R
Bioorg Chem; 2018 Oct; 80():189-194. PubMed ID: 29940340
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel pyrazolopyrimidines derivatives as anticancer and anti-5-lipoxygenase agents.
Rahmouni A; Souiei S; Belkacem MA; Romdhane A; Bouajila J; Ben Jannet H
Bioorg Chem; 2016 Jun; 66():160-8. PubMed ID: 27179178
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 5-benzylidenerhodanine-3-acetic acid derivatives as AChE and 15-LOX inhibitors.
Shafii N; Khoobi M; Amini M; Sakhteman A; Nadri H; Moradi A; Emami S; Saeedian Moghadam E; Foroumadi A; Shafiee A
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):389-95. PubMed ID: 26095345
[TBL] [Abstract][Full Text] [Related]
7. Exploring phenylcarbamoylazinane-1,2,4-triazole thioethers as lipoxygenase inhibitors supported with in vitro, in silico and cytotoxic studies.
Shahid W; Ashraf M; Saleem M; Bashir B; Muzaffar S; Ali M; Kaleem A; Aziz-Ur-Rehman ; Amjad H; Bhattarai K; Riaz N
Bioorg Chem; 2021 Oct; 115():105261. PubMed ID: 34416506
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and biological screening of N-substituted derivatives of 5-benzyl-1,3,4-oxadiazole-2yl-2"-sulfanyl acetamide.
Siddiqui SZ; Rehman A; Abbasi MA; Abbas N; Khan KM; Ashraf M; Ejaz SA
Pak J Pharm Sci; 2013 May; 26(3):455-63. PubMed ID: 23625417
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, molecular properties, anti-inflammatory and anticancer activities of novel 3-hydroxyflavone derivatives.
Znati M; Bordes C; Forquet V; Lantéri P; Ben Jannet H; Bouajila J
Bioorg Chem; 2019 Aug; 89():103009. PubMed ID: 31158579
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of New Arylidene 2,5-Diketopiperazines and Evaluation of their Anti-Acetylcholinesterase, Anti-xanthine Oxidase, Anti-diabetic and Cytotoxic Activities.
Belkacem MA; Jannet HB; Ferhout H; Mzali L; Bouajila J
Med Chem; 2017; 13(8):744-752. PubMed ID: 28480832
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.
Khan I; Zaib S; Ibrar A; Rama NH; Simpson J; Iqbal J
Eur J Med Chem; 2014 May; 78():167-77. PubMed ID: 24681981
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of novel 1,2-oxazine-based small molecules that targets acetylcholinesterase.
Sukhorukov AY; Nirvanappa AC; Swamy J; Ioffe SL; Nanjunda Swamy S; Basappa ; Rangappa KS
Bioorg Med Chem Lett; 2014 Aug; 24(15):3618-21. PubMed ID: 24909082
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of harmine derivatives as potential antitumor agents.
Cao R; Fan W; Guo L; Ma Q; Zhang G; Li J; Chen X; Ren Z; Qiu L
Eur J Med Chem; 2013 Feb; 60():135-43. PubMed ID: 23291116
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Biological Evaluation of New 1,3,4-Oxadiazoles as Potential Anticancer Agents and Enzyme Inhibitors.
Yurttaş L; Çavuşoğlu BK; Çiftçi GA; Temel HE
Anticancer Agents Med Chem; 2018; 18(6):914-921. PubMed ID: 29577865
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents.
Venugopala KN; Govender R; Khedr MA; Venugopala R; Aldhubiab BE; Harsha S; Odhav B
Drug Des Devel Ther; 2015; 9():911-21. PubMed ID: 25733811
[TBL] [Abstract][Full Text] [Related]
16. Further in vitro biological activity evaluation of amino-, thio- and ester-derivatives of avarol.
Tommonaro G; Pejin B; Iodice C; Tafuto A; De Rosa S
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):684-6. PubMed ID: 26114310
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of biologically active O-substituted derivatives of 1-[(3, 5-dichloro-2-hydroxyphenyl)sulfonyl]piperidine.
Khalid H; Rehman A; Abbasi MA; Khan KM; Ashraf M; Ahmad I; Ejaz SA
Pak J Pharm Sci; 2013 May; 26(3):479-85. PubMed ID: 23625420
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis of novel pyranotriazolopyrimidines and evaluation of their anti-soybean lipoxygenase, anti-xanthine oxidase, and cytotoxic activities.
Saïd AB; Romdhane A; Elie N; Touboul D; Jannet HB; Bouajila J
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1277-85. PubMed ID: 26681513
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and biological screening of sulfonamides derived form 2-phenylethylamine.
Rehman AU; Afroz S; Abbasi MA; Tanveer W; Khan KM; Ashraf M; Ahmad I; Afzal I; Ambreen N
Pak J Pharm Sci; 2012 Oct; 25(4):809-14. PubMed ID: 23009998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]